CAS No. |
1366000-58-9 |
|---|---|
中文名称 |
乙酸(1/1)盐:((4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,49S,52R)-52-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-氨基-3-羟基丙酰胺基)-4-甲基戊酰胺基)-5-胍基戊酰胺基)-5-胍基戊酰胺基)-3-羟基丙酰胺基)-3-羟基丙酰胺基)-19-(3-氨基-3-氧代丙基)-49-苄基-28-((S)-仲丁基)-34-(羧甲基)-31,40-双(3-胍基丙基)-16-(羟甲基)-10-异丁基-22-甲基-37-(2-(甲硫基)乙基)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-十六氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-十六氮杂环三十五烷-4-羰基)-L-天冬酰-L-丝酰-L-苯丙氨酰-L-精氨酰-L-酪氨酰化合物 |
英文名称 |
((4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,49S,52R)-52-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-amino-3-hydroxypropanamido)-4-methylpentanamido)-5-guanidinopentanamido)-5-guanidinopentanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-19-(3-amino-3-oxopropyl)-49-benzyl-28-((S)-sec-butyl)-34-(carboxymethyl)-31,40-bis(3-guanidinopropyl)-16-(hydroxymethyl)-10-isobutyl-22-methyl-37-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carbonyl)-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-L-tyrosine--acetic acid (1/1) |
别名 |
Carperitide,HANP | hANP(99-126) | Human atrial natriuretic peptide | SUN 4936 | SUN 4936h | SUN 4936r |
标准英文名 |
((4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,49S,52R)-52-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-amino-3-hydroxypropanamido)-4-methylpentanamido)-5-guanidinopentanamido)-5-guanidinopentanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-19-(3-amino-3-oxopropyl)-49-benzyl-28-((S)-sec-butyl)-34-(carboxymethyl)-31,40-bis(3-guanidinopropyl)-16-(hydroxymethyl)-10-isobutyl-22-methyl-37-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carbonyl)-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-L-tyrosine--acetic acid (1/1) |
分子式 |
C129H207N45O41S3 |
分子量 |
3140.55 |
精确分子量 |
3138.47 |
SMILES |
CC(=O)O.CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O |
标准SMILES |
CC(O)=O.CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)CNC(=O)[C@H](CC2C=CC=CC=2)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO |
用途 |
Atrial Natriuretic Peptide (ANP) (1-28), human, porcine (Acetate) is a 28-amino acid peptide hormone produced and secreted by the heart in response to cardiac injury and mechanical stretch. It exhibits diuretic, natriuretic, and vasodilatory activities. ANP (1-28) inhibits endothelin-1 secretion stimulated by angiotensin II (Ang II) and thrombin in cultured endothelial cells, including porcine aortic and human umbilical vein endothelial cells, concomitant with an increase in intracellular cyclic GMP (cGMP) levels. It binds with high affinity to glomerular ANP receptors in rat kidneys, stimulating cGMP accumulation without affecting cAMP levels, thereby playing a key role in electrolyte and fluid homeostasis. |
InChIKey |
NYSSIVMKYRVLPL-SYGLLGJNSA-N |
|
|
评论 |
|---|